How Big is the Radiopharmaceuticals Market?
The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30. With the increasing burden of the geriatric population, the incidence of multiple diseases, including cancer, cardiovascular diseases (CVDs), etc., is expected to increase enormously across the world. According to the American Society of Clinical Oncology (ASCO), most people who are diagnosed with cancer are older than 65. As a result, the adoption of radiopharmaceuticals for the diagnosis as well as the treatment of cancer, CVDs, and other diseases would increase, propelling the overall Radiopharmaceuticals Market. For instance, as per the World Health Organisation (WHO), it has been estimated that by 2030, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. Further, the world’s population of people aged 60 years and older will reach around 2.1 billion by 2050.
Market Statistics
- Market Size in 2024: USD 7.11 billion
- Market Size By 2030: USD 12.73 billion
- Market Growth Rate (CAGR): 10.19% from 2025-2030
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
Radiopharmaceuticals Market Insight:
Driver-
Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.
With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals.
Radiopharmaceuticals Market Segmentation:
The report has segmented the market into the following categories:
By Radioisotope
- Technetium 99- Market Size & Forecast 2020-2030, USD Million
- Fluorine 18- Market Size & Forecast 2020-2030, USD Million
- Iodine 131- Market Size & Forecast 2020-2030, USD Million
- Gallium 68- Market Size & Forecast 2020-2030, USD Million
- Iodine 123- Market Size & Forecast 2020-2030, USD Million
- Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
By Indication
- Oncology- Market Size & Forecast 2020-2030, USD Million
- Cardiology- Market Size & Forecast 2020-2030, USD Million
- Gastroenterology- Market Size & Forecast 2020-2030, USD Million
- Nephrology- Market Size & Forecast 2020-2030, USD Million
- Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
By Type
- Diagnostic- Market Size & Forecast 2020-2030, USD Million
- Therapeutic- Market Size & Forecast 2020-2030, USD Million
By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
- Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
Competitive Landscape:
- Bayer AG
- Iso-Tex Diagnostics, Inc.
- Jubilant Pharmova Limited
- Novartis AG
- General Electric Company
- Lantheus Holdings, Inc.
- Eli Lilly and Company
- Siemens Healthineers AG
- Curium Pharma
- Cardinal Health
- Blue Earth Diagnostics, Inc. (Bracco Group)
- Acrotech Biopharm
- Northstar Medical Technologies LLC
- IBA Radiopharma Solutions
- Sun Pharmaceutical Industries, Inc.
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*
Key Highlights of the Report:
- Market Performance (2025-2030)
- Strategic Recommendations
- Current, Historical and Future Market Trends
- Market Drivers and Leading Competitor
- SWOT Analysis
- Structure of the Market
- Comprehensive Mapping and Recent Advancement
Other Report:
- Secure Access Service Edge Market Size, Trends Share & Growth By 2030
- Automated Liquid Handling Market Grow at CAGR of 8.7% by 2027 – MarkNtel Advisors
- Middle East & Africa Water & Wastewater Treatment Chemicals Market Analysis 2022-27
- Global Automotive Lubricants Market Share, Size | Analysis & Report 2028
- Automotive Seats Market Size, Share, Trends & Analysis, 2028 MarkNtel
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
